Blau Farmaceutica SA
BOVESPA:BLAU3
Wall Street
Price Targets
BLAU3 Price Targets Summary
Blau Farmaceutica SA
According to Wall Street analysts, the average 1-year price target for
BLAU3
is 18.3 BRL
with a low forecast of 15.15 BRL and a high forecast of 23.63 BRL.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BLAU3's stock price target?
Price Target
18.3
BRL
According to Wall Street analysts, the average 1-year price target for
BLAU3
is 18.3 BRL
with a low forecast of 15.15 BRL and a high forecast of 23.63 BRL.
What is Blau Farmaceutica SA's Revenue forecast?
Projected CAGR
13%
For the last 7 years the
compound annual growth rate for
Blau Farmaceutica SA's revenue is
16%.
The projected
CAGR
for the next 3 years is
13%.
What is Blau Farmaceutica SA's Operating Income forecast?
Projected CAGR
20%
For the last 7 years the
compound annual growth rate for
Blau Farmaceutica SA's operating income is
10%.
The projected
CAGR
for the next 3 years is
20%.
What is Blau Farmaceutica SA's Net Income forecast?
Projected CAGR
20%
For the last 7 years the
compound annual growth rate for
Blau Farmaceutica SA's net income is
11%.
The projected
CAGR
for the next 3 years is
20%.
You don't have any saved screeners yet
